<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref149">
 <mixed-citation publication-type="journal" id="cit149">
  <name>
   <surname>Tao</surname>
   <given-names>W.</given-names>
  </name>; 
  <name>
   <surname>Hurst</surname>
   <given-names>B. L.</given-names>
  </name>; 
  <name>
   <surname>Shakya</surname>
   <given-names>A. K.</given-names>
  </name>; 
  <name>
   <surname>Uddin</surname>
   <given-names>M. J.</given-names>
  </name>; 
  <name>
   <surname>Ingrole</surname>
   <given-names>R. S. J.</given-names>
  </name>; 
  <name>
   <surname>Hernandez-Sanabria</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Arya</surname>
   <given-names>R. P.</given-names>
  </name>; 
  <name>
   <surname>Bimler</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Paust</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Tarbet</surname>
   <given-names>E. B.</given-names>
  </name>; 
  <name>
   <surname>Gill</surname>
   <given-names>H. S.</given-names>
  </name>
  <article-title>Consensus M2e Peptide Conjugated to Gold Nanoparticles Confers Protection against H1N1, H3N2 and H5N1 Influenza A Viruses</article-title>. 
  <source>Antiviral Res.</source>
  <year>2017</year>, 
  <volume>141</volume>, 
  <fpage>62</fpage>â€“
  <lpage>72</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.01.021</pub-id>.
  <pub-id pub-id-type="pmid">28161578</pub-id>
 </mixed-citation>
</ref>
